Browsing by Author "Lazic, Zorica (24830912400)"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Characteristics of copd phenotypes in serbia(2021) ;Lazic, Zorica (24830912400) ;Stankovic, Ivana (13604993500) ;Milenkovic, Branislava (23005307400) ;Zvezdin, Biljana (32868275200) ;Hromis, Sanja (32867618500) ;Jankovic, Slobodan (7101906319)Cupurdija, Vojislav (24830441800)Background: Establishing a regional/national/international registry of patients suffering from chronic obstructive pulmonary disease (COPD) is essential for both research and healthcare, because it enables collection of comprehensive real-life data from a large number of individuals. Objective: The aim of this study was to describe characteristics of COPD patients from the Serbian patient registry, and to investigate actual differences of those characteristics among the COPD phenotypes. Methods: The Serbian registry of patients with COPD was established in 2018 at University of Kragujevac, Faculty of Medical Sciences, based on an online platform. Entry in the Registry was allowed for patients who were diagnosed with COPD according to the following criteria: symptoms of dyspnea, chronic cough or sputum production, history of risk factors for COPD and any degree of persistent airflow limitation diagnosed at spirometry. Results: In the Serbian COPD registry B and D GOLD group were dominant, while among the COPD phenotypes, the most prevalent were non-exacerbators (49.4%) and then frequent exacerbators without chronic bronchitis (29.6%). The frequent exacerbator with chronic bronchitis phenotype was associated with low levels of bronchopulmonary function and absolute predominance of GOLD D group. Anxiety, depression, insomnia, hypertension and chronic heart failure were the most prevalent in the frequent exacerbator with chronic bronchitis phenotype; patients with this phenotype were also treated more frequently than other patients with a triple combination of the most effective inhaled anti-obstructive drugs: long-acting muscarinic antagonists, long-acting beta 2 agonists and corticosteroids. Conclusion: In conclusion, the data from the Serbian registry are in line with those from other national registries, showing that frequent exacerbators with chronic bronchitis have worse bronchopulmonary function, more severe signs and symptoms, and more comorbidities (especially anxiety and depression) than other phenotypes. Other studies also confirmed worse quality of life and worse prognosis of the AE-CB phenotype, stressing importance of both preventive and appropriate therapeutic measures against chronic bronchitis. © 2021 Lazic et al. - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis and management of chronic obstructive pulmonary disease in Serbia: An expert group position statement(2019) ;Vukoja, Marija (57216932269) ;Kopitovic, Ivan (36056890700) ;Lazic, Zorica (24830912400) ;Milenkovic, Branislava (23005307400) ;Stankovic, Ivana (13604993500) ;Zvezdin, Biljana (32868275200) ;Ilic, Aleksandra Dudvarski (7004055911) ;Cekerevac, Ivan (24830194100) ;Vukcevic, Miodrag (6602095465) ;Zugic, Vladimir (13410862400)Hromis, Sanja (32867618500)In recent years, several national chronic obstructive pulmonary disease (COPD) guidelines have been issued. In Serbia, the burden of COPD is high and most of the patients are diagnosed at late stages. Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy is poorly implemented in real-life practice, as many patients are still prescribed inhaled corticosteroids (ICS)-containing regimens and slow-release theophylline. In this document, we propose an algorithm for treating COPD patients in Serbia based on national experts’ opinion, taking into account global recommendations and recent findings from clinical trials that are tailored according to local needs. We identified four major components of COPD treatment based on country specifics: Active case finding and early diagnosis in high-risk population, therapeutic algorithm for initiation and escalation of therapy that is simple and easy to use in real-life practice, de-escalation of ICS in low-risk non-exacerbators, and individual choice of inhaler device based on patients' ability and preferences. With this approach we aim to facilitate implementation of the recommendation, initiate the treatment in early stages, improve cost-effectiveness, reduce possible side effects, and ensure efficient treatment. © 2019 Vukoja et al. - Some of the metrics are blocked by yourconsent settings
Publication Diagnosis and treatment of adult asthma patients in Serbia: a 2022 experts group position statement(2022) ;Vukoja, Marija (57216932269) ;Kopitovic, Ivan (36056890700) ;Lazic, Zorica (24830912400) ;Milenkovic, Branislava (23005307400) ;Stankovic, Ivana (13604993500) ;Tomic-Spiric, Vesna (6603500319) ;Zvezdin, Biljana (32868275200) ;Hromis, Sanja (32867618500) ;Cekerevac, Ivan (24830194100) ;Ilic, Aleksandra (7004055911) ;Vukcevic, Miodrag (6602095465) ;Dimic-Janjic, Sanja (58019271900)Stjepanovic, Mihailo (55052044500)Introduction: Asthma is the most common non-communicable chronic lung condition across all ages. Epidemiological data indicate that many asthma patients in Serbia remain undiagnosed and untreated. The implementation of recent global advances in asthma management is limited due to the lack of a systematic approach, drug availability and regulatory affairs. In addition, the global coronavirus disease pandemic has posed a significant challenge, particularly in resource-limited settings. Areas covered: In this paper, we propose an algorithm for treating adult asthma patients in Serbia. We performed PubMed database search on published asthma clinical trials and guidelines from 1 January 2015 to 10 March 2020. The consensus process incorporated a modified Delphi method that included two rounds of e-mail questionnaires and three rounds of national asthma expert meetings. We focus on 1) objective diagnosis of asthma, 2) the implementation of up-to-date therapeutic options, and 3) the identification and referral of severe asthma patients to newly established severe asthma centers. Expert opinion: Regional specificities and variations in healthcare systems require the adaptation of evidence-based knowledge. Practical, clinically oriented algorithms designed to overcome local barriers in healthcare delivery may facilitate timely and adequate asthma diagnosis and the local implementation of current advances in asthma management. © 2022 Informa UK Limited, trading as Taylor & Francis Group.
